The pharmaceutical corporate presence in developing countries:
This important volume examines the ethical concerns of multinational corporations in the production, distribution, and use of pharmaceuticals in Africa, Asia, and Latin America
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Notre Dame, Ind.
Univ. of Notre Dame Press
1993
|
| Schriftenreihe: | Multinational managers and devoloping country concerns
4 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Zusammenfassung: | This important volume examines the ethical concerns of multinational corporations in the production, distribution, and use of pharmaceuticals in Africa, Asia, and Latin America The 33 contributors to the book, which include pharmaceutical executives, religious activists, consumer advocates, officials of nongovernmental organizations, representatives from the World Health Organization, and academics, explore ways in which multinational managers can direct the resources of their firms toward the amelioration of poverty in the Third World, while maintaining the economic viability of their corporations The book begins by analyzing the overall issue of multinational pharmaceutical corporate involvement in Third World locations. The contributors discuss the broad issue of conflict and collaboration between multinational corporations and activists, the role of pharmaceuticals in Third World health care, and the role of multinational corporations in that process |
| Beschreibung: | XXII, 366 S. |
| ISBN: | 0268015112 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV009617708 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 940530s1993 |||| 00||| engod | ||
| 020 | |a 0268015112 |9 0-268-01511-2 | ||
| 035 | |a (OCoLC)28749422 | ||
| 035 | |a (DE-599)BVBBV009617708 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 050 | 0 | |a HD9674.D442 | |
| 082 | 0 | |a 338.8/8716151/091724 |2 20 | |
| 245 | 1 | 0 | |a The pharmaceutical corporate presence in developing countries |c Lee A. Tavis, ... ed. |
| 264 | 1 | |a Notre Dame, Ind. |b Univ. of Notre Dame Press |c 1993 | |
| 300 | |a XXII, 366 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Multinational managers and devoloping country concerns |v 4 | |
| 520 | 3 | |a This important volume examines the ethical concerns of multinational corporations in the production, distribution, and use of pharmaceuticals in Africa, Asia, and Latin America | |
| 520 | |a The 33 contributors to the book, which include pharmaceutical executives, religious activists, consumer advocates, officials of nongovernmental organizations, representatives from the World Health Organization, and academics, explore ways in which multinational managers can direct the resources of their firms toward the amelioration of poverty in the Third World, while maintaining the economic viability of their corporations | ||
| 520 | |a The book begins by analyzing the overall issue of multinational pharmaceutical corporate involvement in Third World locations. The contributors discuss the broad issue of conflict and collaboration between multinational corporations and activists, the role of pharmaceuticals in Third World health care, and the role of multinational corporations in that process | ||
| 650 | 4 | |a Entwicklungsländer | |
| 650 | 4 | |a Ethik | |
| 650 | 4 | |a Multinationales Unternehmen | |
| 650 | 4 | |a Developing Countries | |
| 650 | 4 | |a Drug Industry | |
| 650 | 4 | |a Ethics, Pharmacy | |
| 650 | 4 | |a International business enterprises |x Moral and ethical aspects |z Developing countries |v Congresses | |
| 650 | 4 | |a Pharmaceutical Preparations |x supply & distribution | |
| 650 | 4 | |a Pharmaceutical industry |x Moral and ethical aspects |z Developing countries |v Congresses | |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Multinationales Unternehmen |0 (DE-588)4075092-9 |2 gnd |9 rswk-swf |
| 651 | 4 | |a Países subdesarrollados - Empresas internacionales - Aspectos morales y éticos - Congresos | |
| 651 | 7 | |a Entwicklungsländer |0 (DE-588)4014954-7 |2 gnd |9 rswk-swf | |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Entwicklungsländer |0 (DE-588)4014954-7 |D g |
| 689 | 0 | 1 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 0 | 2 | |a Multinationales Unternehmen |0 (DE-588)4075092-9 |D s |
| 689 | 0 | 3 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Entwicklungsländer |0 (DE-588)4014954-7 |D g |
| 689 | 1 | 1 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |D s |
| 689 | 1 | 2 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Tavis, Lee A. |e Sonstige |4 oth | |
| 830 | 0 | |a Multinational managers and devoloping country concerns |v 4 |w (DE-604)BV009617695 |9 4 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006356063&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006356063 | ||
Datensatz im Suchindex
| _version_ | 1804123957078523904 |
|---|---|
| adam_text | Contents
Foreword • Rev. Theodore M. Hesburgh, C.S.C. xi
Acknowledgments xv
Introduction xvii
PART 1: THE ROLE OF MULTINATIONAL
PHARMACEUTICAL CORPORATIONS 1
Theological Ethics and the Multinational:
A Changing Relationship • Oliver F. Williams, C.S.C 3
Pharmaceuticals and Developing Countries • Louis Lasagna, M.D. 15
Response • Jean Halloran 2 5
• David E. Collins 29
Discussion Summary 33
Multinational Pharmaceutical Corporations and Developing
Countries • Klaus M. Leisinger 41
Response • Ingar G. F Bruggemann 63
• James B. Russo 69
Discussion Summary 73
PART 2: GLOBAL PHARMACEUTICAL ISSUES 77
EESSENTIAL DRUGS 81
Essential Drugs: Economics and Politics in International
Health • MichaelR. Reich 83
The World Health Organization Action Programme on
Essential Drugs • Fernando S. Antezana 109
Health Services Delivery: UNICEF s Bamako Initiative
• Agostino Paganini, M.D. andStephen Jarre tt 123
vii
viii Contents
Response • Robert T. McDonough 141
• Paul A. Belford 145
• Linda Pfeiffer 149
Discussion Summary 153
COUNTERFEIT DRUGS 159
Global Syndicates and the Threat to Third World Health
• VedP. Kumar 161
The Ugliest Form of Medical Corruption • Gabriel Daniel 175
Response • Alberta R. Edwards 181
• Michael L. Privitera 185
Discussion Summary 189
INTELLECTUAL PROPERTY RIGHTS 195
Intellectual Property: The U.S. Concern • Philip G. Ellsworth 197
Developing Country Concerns from an Industry Perspective
• Michael A. O Neill 203
Discussion Summary 211
PART 3: THE KENYAN EXPERIENCE: FIRST WORLD MEDICINE
IN A THIRD WORLD SETTING 217
Traditional Medicine • Violet N. Kimani 219
Modern Health Care in Kenya • John P. Thorp 229
Pharmaceuticals in Kenyan Government Health Care
• Gerald D. Moore 265
Pharmaceuticals in Kenyan Christian Health Services
• Joan Devane, S.C.M.M. 277
Response from Africa • H. Thomas McDermott, C.S.C. 287
• Mutombo Mpanya 291
Response from Industry • Susan Crowley 299
• E. Steven Bauer 301
Discussion Summary 305
Considerations for Multinational Managers • Lee A. Tavis 313
Contents ix
PART 4: MORAL COMMITMENTS AND COLLABORATION 339
An Activist Voice • Regina Rowan, S.C.M.M. 341
An Industry Voice • Albert D. Angel 347
Participants 355
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV009617708 |
| callnumber-first | H - Social Science |
| callnumber-label | HD9674 |
| callnumber-raw | HD9674.D442 |
| callnumber-search | HD9674.D442 |
| callnumber-sort | HD 49674 D442 |
| callnumber-subject | HD - Industries, Land Use, Labor |
| ctrlnum | (OCoLC)28749422 (DE-599)BVBBV009617708 |
| dewey-full | 338.8/8716151/091724 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.8/8716151/091724 |
| dewey-search | 338.8/8716151/091724 |
| dewey-sort | 3338.8 78716151 591724 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03792nam a2200661 cb4500</leader><controlfield tag="001">BV009617708</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">940530s1993 |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0268015112</subfield><subfield code="9">0-268-01511-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)28749422</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009617708</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9674.D442</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.8/8716151/091724</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The pharmaceutical corporate presence in developing countries</subfield><subfield code="c">Lee A. Tavis, ... ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Notre Dame, Ind.</subfield><subfield code="b">Univ. of Notre Dame Press</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXII, 366 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Multinational managers and devoloping country concerns</subfield><subfield code="v">4</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">This important volume examines the ethical concerns of multinational corporations in the production, distribution, and use of pharmaceuticals in Africa, Asia, and Latin America</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The 33 contributors to the book, which include pharmaceutical executives, religious activists, consumer advocates, officials of nongovernmental organizations, representatives from the World Health Organization, and academics, explore ways in which multinational managers can direct the resources of their firms toward the amelioration of poverty in the Third World, while maintaining the economic viability of their corporations</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The book begins by analyzing the overall issue of multinational pharmaceutical corporate involvement in Third World locations. The contributors discuss the broad issue of conflict and collaboration between multinational corporations and activists, the role of pharmaceuticals in Third World health care, and the role of multinational corporations in that process</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Entwicklungsländer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ethik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multinationales Unternehmen</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Developing Countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ethics, Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">International business enterprises</subfield><subfield code="x">Moral and ethical aspects</subfield><subfield code="z">Developing countries</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations</subfield><subfield code="x">supply & distribution</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Moral and ethical aspects</subfield><subfield code="z">Developing countries</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Multinationales Unternehmen</subfield><subfield code="0">(DE-588)4075092-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">Países subdesarrollados - Empresas internacionales - Aspectos morales y éticos - Congresos</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Multinationales Unternehmen</subfield><subfield code="0">(DE-588)4075092-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tavis, Lee A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Multinational managers and devoloping country concerns</subfield><subfield code="v">4</subfield><subfield code="w">(DE-604)BV009617695</subfield><subfield code="9">4</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006356063&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006356063</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Aufsatzsammlung Konferenzschrift |
| geographic | Países subdesarrollados - Empresas internacionales - Aspectos morales y éticos - Congresos Entwicklungsländer (DE-588)4014954-7 gnd |
| geographic_facet | Países subdesarrollados - Empresas internacionales - Aspectos morales y éticos - Congresos Entwicklungsländer |
| id | DE-604.BV009617708 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T17:38:01Z |
| institution | BVB |
| isbn | 0268015112 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006356063 |
| oclc_num | 28749422 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | XXII, 366 S. |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Univ. of Notre Dame Press |
| record_format | marc |
| series | Multinational managers and devoloping country concerns |
| series2 | Multinational managers and devoloping country concerns |
| spelling | The pharmaceutical corporate presence in developing countries Lee A. Tavis, ... ed. Notre Dame, Ind. Univ. of Notre Dame Press 1993 XXII, 366 S. txt rdacontent n rdamedia nc rdacarrier Multinational managers and devoloping country concerns 4 This important volume examines the ethical concerns of multinational corporations in the production, distribution, and use of pharmaceuticals in Africa, Asia, and Latin America The 33 contributors to the book, which include pharmaceutical executives, religious activists, consumer advocates, officials of nongovernmental organizations, representatives from the World Health Organization, and academics, explore ways in which multinational managers can direct the resources of their firms toward the amelioration of poverty in the Third World, while maintaining the economic viability of their corporations The book begins by analyzing the overall issue of multinational pharmaceutical corporate involvement in Third World locations. The contributors discuss the broad issue of conflict and collaboration between multinational corporations and activists, the role of pharmaceuticals in Third World health care, and the role of multinational corporations in that process Entwicklungsländer Ethik Multinationales Unternehmen Developing Countries Drug Industry Ethics, Pharmacy International business enterprises Moral and ethical aspects Developing countries Congresses Pharmaceutical Preparations supply & distribution Pharmaceutical industry Moral and ethical aspects Developing countries Congresses Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Arzneimittelmarkt (DE-588)4003131-7 gnd rswk-swf Gesundheitspolitik (DE-588)4113743-7 gnd rswk-swf Multinationales Unternehmen (DE-588)4075092-9 gnd rswk-swf Países subdesarrollados - Empresas internacionales - Aspectos morales y éticos - Congresos Entwicklungsländer (DE-588)4014954-7 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content Entwicklungsländer (DE-588)4014954-7 g Gesundheitspolitik (DE-588)4113743-7 s Multinationales Unternehmen (DE-588)4075092-9 s Pharmazeutische Industrie (DE-588)4045696-1 s DE-604 Arzneimittelmarkt (DE-588)4003131-7 s Tavis, Lee A. Sonstige oth Multinational managers and devoloping country concerns 4 (DE-604)BV009617695 4 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006356063&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | The pharmaceutical corporate presence in developing countries Multinational managers and devoloping country concerns Entwicklungsländer Ethik Multinationales Unternehmen Developing Countries Drug Industry Ethics, Pharmacy International business enterprises Moral and ethical aspects Developing countries Congresses Pharmaceutical Preparations supply & distribution Pharmaceutical industry Moral and ethical aspects Developing countries Congresses Pharmazeutische Industrie (DE-588)4045696-1 gnd Arzneimittelmarkt (DE-588)4003131-7 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Multinationales Unternehmen (DE-588)4075092-9 gnd |
| subject_GND | (DE-588)4045696-1 (DE-588)4003131-7 (DE-588)4113743-7 (DE-588)4075092-9 (DE-588)4014954-7 (DE-588)4143413-4 (DE-588)1071861417 |
| title | The pharmaceutical corporate presence in developing countries |
| title_auth | The pharmaceutical corporate presence in developing countries |
| title_exact_search | The pharmaceutical corporate presence in developing countries |
| title_full | The pharmaceutical corporate presence in developing countries Lee A. Tavis, ... ed. |
| title_fullStr | The pharmaceutical corporate presence in developing countries Lee A. Tavis, ... ed. |
| title_full_unstemmed | The pharmaceutical corporate presence in developing countries Lee A. Tavis, ... ed. |
| title_short | The pharmaceutical corporate presence in developing countries |
| title_sort | the pharmaceutical corporate presence in developing countries |
| topic | Entwicklungsländer Ethik Multinationales Unternehmen Developing Countries Drug Industry Ethics, Pharmacy International business enterprises Moral and ethical aspects Developing countries Congresses Pharmaceutical Preparations supply & distribution Pharmaceutical industry Moral and ethical aspects Developing countries Congresses Pharmazeutische Industrie (DE-588)4045696-1 gnd Arzneimittelmarkt (DE-588)4003131-7 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Multinationales Unternehmen (DE-588)4075092-9 gnd |
| topic_facet | Entwicklungsländer Ethik Multinationales Unternehmen Developing Countries Drug Industry Ethics, Pharmacy International business enterprises Moral and ethical aspects Developing countries Congresses Pharmaceutical Preparations supply & distribution Pharmaceutical industry Moral and ethical aspects Developing countries Congresses Pharmazeutische Industrie Arzneimittelmarkt Gesundheitspolitik Países subdesarrollados - Empresas internacionales - Aspectos morales y éticos - Congresos Aufsatzsammlung Konferenzschrift |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006356063&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV009617695 |
| work_keys_str_mv | AT tavisleea thepharmaceuticalcorporatepresenceindevelopingcountries |